Korean Psychiatrists Describe GenAI Uses and Priorities

According to a JMIR preprint by Kim et al., the authors report a qualitative study that explored how generative AI is manifesting in psychiatric practice among South Korean psychiatrists. The preprint states clinicians described encounters with patient-facing chatbots, self-help tools, and clinician-facing workflow support in clinical settings. The paper argues that potential benefits and harms of GenAI in psychiatry depend on patient vulnerability, crisis sensitivity, and the therapeutic relationship, and uses selected horizon-scanning concepts to organise the analysis (JMIR preprint).

Editorial analysis: The study is practice-focused rather than a systems or algorithmic evaluation. For practitioners, this type of qualitative work highlights the gap between deployed user-facing GenAI tools and formal clinical validation. Industry-pattern observations note that clinician-facing signals often surface issues around data provenance, consent, and failure modes in crisis scenarios rather than model architecture or benchmark scores.

Editorial analysis: Practice-based signals are valuable to translate high-level AI policy into actionable clinical guidance. Studies that sample frontline clinician experience complement technical audits and regulatory reviews by documenting how tools are actually used, misunderstood, or repurposed in everyday care. For psychiatric care specifically, the preprint frames concerns about patient vulnerability and crisis handling as central, aligning with prior literature that prioritises safety and therapeutic continuity over narrow performance metrics.

• •Whether the JMIR preprint is revised or expanded after peer review and what methodological details are added.
• •Publication of complementary empirical work that quantifies safety incidents or outcome differences where GenAI tools are in routine use.
• •Guidance from clinical societies or regulators addressing consent, disclosure, and crisis escalation when GenAI tools interact with psychiatric patients.

Editorial analysis: Observers and practitioners should treat this paper as an early, qualitative signal rather than definitive evidence about efficacy or risk. The value of the study lies in surfacing clinician perspectives and implementation priorities that can guide follow-up quantitative research and policy development.